Application 021065

Type
NDA
Sponsor
APIL

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001FEMHRTETHINYL ESTRADIOL; NORETHINDRONE ACETATETABLET;ORAL0.0025MG;0.5MGNoNo
002FEMHRTETHINYL ESTRADIOL; NORETHINDRONE ACETATETABLET;ORAL0.005MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0430-0145femhrtnorethindrone acetate/ethinyl estradiolAllergan, Inc.NDACurrent
0430-0145femhrtnorethindrone acetate/ethinyl estradiolAllergan, Inc.NDACurrent
52544-236Jevantique LoNorethindrone Acetate and Ethinyl EstradiolActavis Pharma, Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
74336SUPPL 2023-05-22
74335SUPPL 2023-05-22
74319SUPPL 2023-05-19
74318SUPPL 2023-05-19
50277SUPPL2017-11-02
35993SUPPL2014-01-10
4187SUPPL2014-01-10
26612SUPPL2005-01-21
14269SUPPL2005-01-21
35992SUPPL2004-01-22
26611SUPPL2004-01-22
41918ORIG1999-10-15
23065ORIG1999-10-15
14268ORIG1999-10-15
4186ORIG1999-10-15